Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Altman

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Allergy and Clinical Immunology|January 9, 2025
Dysregulation of airway and systemic interferon responses promotes asthma exacerbations in urban childrenCourtney L Gaberino, Matthew C Altman, Michelle A Gill, et al.
The Journal of Allergy and Clinical Immunology|March 14, 2023
Airway transcriptome networks identify susceptibility to frequent asthma exacerbations in childrenKieran J Phelan, Kimberly A Dill-McFarland, Arjun Kothari, et al.
The Journal of Allergy and Clinical Immunology|October 12, 2022
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trialJonathan Corren, David Larson, Matthew C Altman, et al.
Nature Communications|January 9, 2024
IgM N-glycosylation correlates with COVID-19 severity and rate of complement depositionBenjamin S Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2020
Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergenDavid Larson, Piyush Patel, Anne Marie Salapatek, et al.
The Journal of Allergy and Clinical Immunology|March 14, 2024
Activated sputum eosinophils associated with exacerbations in children on mepolizumabGabriella E Wilson, James Knight, Qing Liu, et al.
The Journal of Allergy and Clinical Immunology|March 28, 2025
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshopRonald L Rabin, Matthew C Altman, S Hasan Arshad, et al.
Allergy|December 21, 2024
Oncostatin-M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe AsthmaStephane Esnault, Ksenija Bernau, Heather L Floerke, et al.
Nature Communications|September 2, 2025
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthmaCourtney L Gaberino, R Max Segnitz, Kimberly A Dill-McFarland, et al.
Genome Medicine|October 11, 2021
Multi-omics colocalization with genome-wide association studies reveals a context-specific genetic mechanism at a childhood onset asthma risk locusMarcus M Soliai, Atsushi Kato, Britney A Helling, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Allergy and Clinical Immunology|January 9, 2025
Dysregulation of airway and systemic interferon responses promotes asthma exacerbations in urban childrenCourtney L Gaberino, Matthew C Altman, Michelle A Gill, et al.
The Journal of Allergy and Clinical Immunology|March 14, 2023
Airway transcriptome networks identify susceptibility to frequent asthma exacerbations in childrenKieran J Phelan, Kimberly A Dill-McFarland, Arjun Kothari, et al.
The Journal of Allergy and Clinical Immunology|October 12, 2022
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trialJonathan Corren, David Larson, Matthew C Altman, et al.
Nature Communications|January 9, 2024
IgM N-glycosylation correlates with COVID-19 severity and rate of complement depositionBenjamin S Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2020
Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergenDavid Larson, Piyush Patel, Anne Marie Salapatek, et al.
The Journal of Allergy and Clinical Immunology|March 14, 2024
Activated sputum eosinophils associated with exacerbations in children on mepolizumabGabriella E Wilson, James Knight, Qing Liu, et al.
The Journal of Allergy and Clinical Immunology|March 28, 2025
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshopRonald L Rabin, Matthew C Altman, S Hasan Arshad, et al.
Allergy|December 21, 2024
Oncostatin-M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe AsthmaStephane Esnault, Ksenija Bernau, Heather L Floerke, et al.
Nature Communications|September 2, 2025
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthmaCourtney L Gaberino, R Max Segnitz, Kimberly A Dill-McFarland, et al.
Genome Medicine|October 11, 2021
Multi-omics colocalization with genome-wide association studies reveals a context-specific genetic mechanism at a childhood onset asthma risk locusMarcus M Soliai, Atsushi Kato, Britney A Helling, et al.
Pageof 12